Free Trial

Carisma Therapeutics (CARM) Short Interest Ratio & Short Volume

Carisma Therapeutics logo
$0.22 0.00 (-1.24%)
As of 04/24/2025 04:00 PM Eastern

Carisma Therapeutics Short Interest Data

Carisma Therapeutics (CARM) has a short interest of 484,900 shares, representing 2.32% of the float (the number of shares available for trading by the public). This marks a 13.53% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 380,473 shares to cover all short positions.

Current Short Interest
484,900 shares
Previous Short Interest
427,100 shares
Change Vs. Previous Month
+13.53%
Dollar Volume Sold Short
$150,319.00
Short Interest Ratio
1.6 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
41,788,000 shares
Float Size
20,940,000 shares
Short Percent of Float
2.32%
Today's Trading Volume
281,673 shares
Average Trading Volume
380,473 shares
Today's Volume Vs. Average
74%
Short Selling Carisma Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Carisma Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CARM Short Interest Over Time

CARM Days to Cover Over Time

CARM Percentage of Float Shorted Over Time

Carisma Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2025484,900 shares $150,319.00 +13.5%2.3%1.6 $0.31
3/15/2025427,100 shares $175,538.10 -8.0%2.0%1.4 $0.41
2/28/2025464,400 shares $186,224.40 -22.2%2.2%1.3 $0.40
2/15/2025596,500 shares $293,478.00 -16.5%2.9%1.7 $0.49
1/31/2025714,400 shares $328,481.12 +63.1%3.3%1.9 $0.46
1/15/2025437,900 shares $195,128.24 -18.6%2.0%1.7 $0.45
12/31/2024537,700 shares $225,188.76 -5.4%2.5%2.1 $0.42
12/15/2024568,400 shares $230,088.32 +2.6%2.6%2.6 $0.40
11/30/2024554,200 shares $473,397.64 -0.8%2.6%3.4 $0.85
11/15/2024558,600 shares $493,355.52 -34.9%2.6%3.8 $0.88
10/31/2024857,500 shares $834,776.25 -18.3%4.0%5.9 $0.97
10/15/20241,050,000 shares $997,290.00 -4.6%4.9%7 $0.95
9/30/20241,100,000 shares $1.08 million -2.7%5.2%5.8 $0.98
9/15/20241,130,000 shares $1.15 million +2.7%5.3%1.4 $1.02
8/31/20241,100,000 shares $1.18 million -1.8%5.3%1.4 $1.07
8/15/20241,120,000 shares $1.18 million +12.5%5.4%1.4 $1.05
7/31/2024995,900 shares $1.07 million -3.3%4.9%1.2 $1.07
7/15/20241,030,000 shares $1.30 million -47.2%5.1%1.3 $1.26
6/30/20241,950,000 shares $2.96 million +42.3%9.7%2.6 $1.52
6/15/20241,370,000 shares $1.56 million -3.5%6.8%7 $1.14
5/31/20241,420,000 shares $1.89 million -9.6%7.0%7.8 $1.33
5/15/20241,570,000 shares $2.20 million -13.7%7.8%9 $1.40
4/30/20241,820,000 shares $2.97 million +10.3%9.4%11 $1.63
4/15/20241,650,000 shares $2.90 million +4.4%8.5%10 $1.76
3/31/20241,580,000 shares $3.59 million +1.9%8.2%10.1 $2.27
3/15/20241,550,000 shares $3.60 million -25.5%8.2%10.6 $2.32
2/29/20242,080,000 shares $5.37 million -13.3%11.1%12.5 $2.58
2/15/20242,400,000 shares $5.50 million -0.8%12.8%13.9 $2.29
1/31/20242,420,000 shares $5.08 million +1.7%12.9%14.4 $2.10
1/15/20242,380,000 shares $6.16 million +10.2%12.8%13.3 $2.59
12/31/20232,160,000 shares $6.33 million -4.0%11.6%10.4 $2.93
12/15/20232,250,000 shares $5.90 million -8.2%12.1%10.3 $2.62
11/30/20232,450,000 shares $5.88 million +2.5%13.2%11.2 $2.40
11/15/20232,390,000 shares $6.12 million +8.1%12.9%11.5 $2.56
10/31/20232,210,000 shares $6.63 million -8.7%11.9%10.8 $3.00
10/15/20232,420,000 shares $8.28 million -2.4%13.1%10.1 $3.42
9/30/20232,480,000 shares $10.49 million -3.9%13.4%11.1 $4.23
9/15/20232,580,000 shares $12.90 million -8.5%13.9%11 $5.00
8/31/20232,820,000 shares $19.51 million -1.7%15.2%9 $6.92
8/15/20232,870,000 shares $19.63 million +3.6%15.5%8.8 $6.84
URGENT: Someone's Moving Gold Out of London... (Ad)

People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.

Go here to learn about my Top Four picks for the coming bull mania.
7/31/20232,770,000 shares $15.37 million +13.1%15.0%8.2 $5.55
7/15/20232,450,000 shares $23.25 million +7.9%13.3%7.8 $9.49
6/30/20232,270,000 shares $19.91 million +246.1%12.3%7.4 $8.77
6/15/2023655,900 shares $4.85 million +25.7%3.6%2.4 $7.40
5/31/2023521,900 shares $2.96 million -18.1%3.2%2.9 $5.67
5/15/2023636,900 shares $3.21 million No Change2.1%3.9 $5.04

CARM Short Interest - Frequently Asked Questions

What is Carisma Therapeutics' current short interest?

Short interest is the volume of Carisma Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 484,900 shares of CARM short. 2.32% of Carisma Therapeutics' shares are currently sold short. Learn More on Carisma Therapeutics' current short interest.

What is a good short interest ratio for Carisma Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CARM shares currently have a short interest ratio of 2.0. Learn More on Carisma Therapeutics's short interest ratio.

Which institutional investors are shorting Carisma Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Carisma Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Carisma Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.32% of Carisma Therapeutics' floating shares are currently sold short.

Is Carisma Therapeutics' short interest increasing or decreasing?

Carisma Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 484,900 shares, an increase of 13.5% from the previous total of 427,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Carisma Therapeutics' float size?

Carisma Therapeutics currently has issued a total of 41,788,000 shares. Some of Carisma Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Carisma Therapeutics currently has a public float of 20,940,000 shares.

How does Carisma Therapeutics' short interest compare to its competitors?

2.32% of Carisma Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Carisma Therapeutics: NRx Pharmaceuticals, Inc. (9.27%), Surrozen, Inc. (18.52%), Alterity Therapeutics Limited (0.30%), Cadrenal Therapeutics, Inc. (4.10%), Pluri Inc. (0.21%), Marinus Pharmaceuticals, Inc. (3.95%), Kezar Life Sciences, Inc. (0.97%), ALX Oncology Holdings Inc. (18.53%), Estrella Immunopharma, Inc. (0.17%), Allakos Inc. (2.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Carisma Therapeutics stock?

Short selling CARM is an investing strategy that aims to generate trading profit from Carisma Therapeutics as its price is falling. CARM shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Carisma Therapeutics?

A short squeeze for Carisma Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CARM, which in turn drives the price of the stock up even further.

How often is Carisma Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARM, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:CARM) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners